Engineering two species of yeast as cell factories for 2'-fucosyllactose.

Oligosaccharides present in human breast milk have been linked to beneficial effects on infant health. Inclusion of these human milk oligosaccharides (HMOs) in infant formula can recapitulate these health benefits. As a result, there is substantial commercial interest in a cost-effective source of HMOs as infant formula ingredients. Here we demonstrate that the yeast species Saccharomyces cerevisiae and Yarrowia lipolytica both can be engineered to produce 2'-fucosyllactose (2'FL), which is the most abundant oligosaccharide in human breast milk, at high titer and productivity. Both yeast species were modified to enable uptake of lactose and synthesis of GDP-fucose - the two precursors of 2'FL - by installing a lactose transporter and enzymes that convert GDP-mannose to GDP-fucose. Production of 2'FL was then enabled by expression of α-1,2-fucosyltransferases from various organisms. By screening candidate transporters from a variety of sources, we identified transporters capable of exporting 2'FL from yeast, which is a key consideration for any biocatalyst for 2'FL production. In particular, we identified CDT2 from Neurospora crassa as a promising target for further engineering to improve 2'FL efflux. Finally, we demonstrated production of 2'FL in fermenters at rates and titers that indicate the potential of engineered S. cerevisiae and Y. lipolytica strains for commercial 2'FL production.

[1]  Chun-Hung Lin,et al.  Characterization of Helicobacter pylori α1,2-Fucosyltransferase for Enzymatic Synthesis of Tumor-Associated Antigens , 2008 .

[2]  L. Bode,et al.  Overcoming the limited availability of human milk oligosaccharides: challenges and opportunities for research and application. , 2016, Nutrition reviews.

[3]  P. Miller,et al.  Functional and Biochemical Characterization of Escherichia coli Sugar Efflux Transporters* , 1999, The Journal of Biological Chemistry.

[4]  B. Nidetzky,et al.  Biotechnological production of fucosylated human milk oligosaccharides: Prokaryotic fucosyltransferases and their use in biocatalytic cascades or whole cell conversion systems. , 2016, Journal of biotechnology.

[5]  N. Callewaert,et al.  Engineering of glycosylation in yeast and other fungi: current state and perspectives , 2010, Applied Microbiology and Biotechnology.

[6]  J. Chapman,et al.  The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome , 2008, Proceedings of the National Academy of Sciences.

[7]  K. Kim,et al.  Production of a human milk oligosaccharide 2′-fucosyllactose by metabolically engineered Saccharomyces cerevisiae , 2018, Microbial Cell Factories.

[8]  P. Mattila,et al.  Functional expression of Escherichia coli enzymes synthesizing GDP-L-fucose from inherent GDP-D-mannose in Saccharomyces cerevisiae. , 2000, Glycobiology.

[9]  Huimin Zhao,et al.  Directed evolution of a cellodextrin transporter for improved biofuel production under anaerobic conditions in Saccharomyces cerevisiae , 2014, Biotechnology and bioengineering.

[10]  Jens Nielsen,et al.  Metabolic engineering of Saccharomyces cerevisiae: a key cell factory platform for future biorefineries , 2012, Cellular and Molecular Life Sciences.

[11]  F. Sherman.  Getting started with yeast. , 1991, Methods in enzymology.

[12]  Sean R. Eddy,et al.  Accelerated Profile HMM Searches , 2011, PLoS Comput. Biol..

[13]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[14]  Lars Bode,et al.  Human milk oligosaccharides: every baby needs a sugar mama. , 2012, Glycobiology.

[15]  Lothar Elling,et al.  WbgL: a novel bacterial α1,2-fucosyltransferase for the synthesis of 2'-fucosyllactose. , 2014, Glycobiology.

[16]  Narmada Thanki,et al.  CDD: NCBI's conserved domain database , 2014, Nucleic Acids Res..

[17]  Stephen J. Van Dien,et al.  From the first drop to the first truckload: commercialization of microbial processes for renewable chemicals. , 2013 .

[18]  E. Nagamori,et al.  The Effect of Pyruvate Decarboxylase Gene Knockout in Saccharomyces cerevisiae on L-Lactic Acid Production , 2006, Bioscience, biotechnology, and biochemistry.

[19]  R. Kumar,et al.  Molecular Cloning of Human GDP-mannose 4,6-Dehydratase and Reconstitution of GDP-fucose Biosynthesis in Vitro * , 1998, The Journal of Biological Chemistry.

[20]  Jin-Ho Seo,et al.  Improved production of 2'-fucosyllactose in engineered Escherichia coli by expressing putative α-1,2-fucosyltransferase, WcfB from Bacteroides fragilis. , 2017, Journal of biotechnology.

[21]  C. Lebrilla,et al.  Breast milk oligosaccharides: structure-function relationships in the neonate. , 2014, Annual review of nutrition.

[22]  C. Roos,et al.  Cloning and expression of Helicobacter pylori GDP-l-fucose synthesizing enzymes (GMD and GMER) in Saccharomyces cerevisiae. , 2001, European journal of biochemistry.

[23]  Jamie H. D. Cate,et al.  Screening of transporters to improve xylodextrin utilization in the yeast Saccharomyces cerevisiae , 2017, PloS one.

[24]  E. O’Shea,et al.  Global analysis of protein localization in budding yeast , 2003, Nature.

[25]  Jia Liu,et al.  Metabolic engineering of Escherichia coli for the production of 2'-fucosyllactose and 3-fucosyllactose through modular pathway enhancement. , 2017, Metabolic engineering.

[26]  W. A. Scheffers,et al.  Effect of benzoic acid on metabolic fluxes in yeasts: A continuous‐culture study on the regulation of respiration and alcoholic fermentation , 1992, Yeast.

[27]  V. Higgins,et al.  Molecular Analysis of Maltotriose Transport and Utilization by Saccharomycescerevisiae , 2002, Applied and Environmental Microbiology.

[28]  B. Stambuk,et al.  Kinetics of active α-glucoside transport in Saccharomyces cerevisiae , 2001 .

[29]  Karen C. Goehring,et al.  Similar to Those Who Are Breastfed, Infants Fed a Formula Containing 2'-Fucosyllactose Have Lower Inflammatory Cytokines in a Randomized Controlled Trial. , 2016, The Journal of nutrition.

[30]  J. Strathern,et al.  Methods in yeast genetics : a Cold Spring Harbor Laboratory course manual , 2005 .

[31]  Jennifer A. Williams,et al.  Infants Fed a Lower Calorie Formula With 2′FL Show Growth and 2′FL Uptake Like Breast-Fed Infants , 2015, Journal of pediatric gastroenterology and nutrition.

[32]  G. Sprenger,et al.  Construction of Escherichia coli strains with chromosomally integrated expression cassettes for the synthesis of 2′-fucosyllactose , 2013, Microbial Cell Factories.

[33]  T. Butt,et al.  SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins , 2004, Journal of Structural and Functional Genomics.

[34]  L. Enquist,et al.  Experiments With Gene Fusions , 1984 .

[35]  B. Stambuk,et al.  Kinetics of active alpha-glucoside transport in Saccharomyces cerevisiae. , 2001, FEMS yeast research.

[36]  Michael J. Miller,et al.  Whole cell biosynthesis of a functional oligosaccharide, 2′-fucosyllactose, using engineered Escherichia coli , 2012, Microbial Cell Factories.

[37]  Wei Zhao,et al.  Biochemical characterization of an α1,2-colitosyltransferase from Escherichia coli O55:H7. , 2016, Glycobiology.

[38]  M. Bolognesi,et al.  Probing the catalytic mechanism of GDP-4-keto-6-deoxy-d-mannose Epimerase/Reductase by kinetic and crystallographic characterization of site-specific mutants. , 2000, Journal of molecular biology.

[39]  Uwe Sauer,et al.  Metabolic-flux and network analysis in fourteen hemiascomycetous yeasts. , 2005, FEMS yeast research.

[40]  T. Panavas,et al.  SUMO fusion technology for enhanced protein production in prokaryotic and eukaryotic expression systems. , 2009, Methods in molecular biology.

[41]  Uwe Sauer,et al.  Intracellular characterization of aerobic glucose metabolism in seven yeast species by 13C flux analysis and metabolomics. , 2011, FEMS yeast research.

[42]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[43]  Jin-Ho Seo,et al.  Metabolic engineering of Escherichia coli to produce 2′‐fucosyllactose via salvage pathway of guanosine 5′‐diphosphate (GDP)‐l‐fucose , 2016, Biotechnology and bioengineering.

[44]  Wei Chen,et al.  Biochemical characterization of GDP-L-fucose de novo synthesis pathway in fungus Mortierella alpina. , 2010, Biochemical and biophysical research communications.

[45]  J. R. Somoza,et al.  Structural and kinetic analysis of Escherichia coli GDP-mannose 4,6 dehydratase provides insights into the enzyme's catalytic mechanism and regulation by GDP-fucose. , 2000, Structure.

[46]  Y. Jigami,et al.  Interaction of GDP-4-keto-6-deoxymannose-3,5-epimerase-4-reductase with GDP-mannose-4,6-dehydratase stabilizes the enzyme activity for formation of GDP-fucose from GDP-mannose. , 2003, Glycobiology.

[47]  Danielle G. Lemay,et al.  Comparative transcriptomics reveals key differences in the response to milk oligosaccharides of infant gut-associated bifidobacteria , 2015, Scientific Reports.

[48]  Jamie H. D. Cate,et al.  Analysis of cellodextrin transporters from Neurospora crassa in Saccharomyces cerevisiae for cellobiose fermentation , 2013, Applied Microbiology and Biotechnology.

[49]  Lily S. Cheung,et al.  Transport of sugars. , 2015, Annual review of biochemistry.

[50]  M. Peaker,et al.  Transport of milk constituents by the mammary gland. , 2000, Physiological reviews.

[51]  A. Kondo,et al.  Expression of varied GFPs in Saccharomyces cerevisiae: codon optimization yields stronger than expected expression and fluorescence intensity , 2016, Scientific Reports.

[52]  W. Yi,et al.  Identification of a new alpha1,2-fucosyltransferase involved in O-antigen biosynthesis of Escherichia coli O86:B7 and formation of H-type 3 blood group antigen. , 2008, Biochemistry.

[53]  L. Stateva,et al.  Genetically controlled cell lysis in the yeast Saccharomyces cerevisiae. , 1999, Biotechnology and bioengineering.

[54]  J. Adrio.  Oleaginous yeasts: Promising platforms for the production of oleochemicals and biofuels. , 2017, Biotechnology and bioengineering.

[55]  Georg A. Sprenger,et al.  Production of human milk oligosaccharides by enzymatic and whole-cell microbial biotransformations. , 2017, Journal of biotechnology.

[56]  Jin-Ho Seo,et al.  Enhanced production of 2'-fucosyllactose in engineered Escherichia coli BL21star(DE3) by modulation of lactose metabolism and fucosyltransferase. , 2015, Journal of biotechnology.

[57]  K. Kim,et al.  Biosynthesis of a Functional Human Milk Oligosaccharide, 2'-Fucosyllactose, and l-Fucose Using Engineered Saccharomyces cerevisiae. , 2018, ACS synthetic biology.

[58]  J. Beckerich,et al.  One-step transformation of the dimorphic yeast Yarrowia lipolytica , 1997, Applied Microbiology and Biotechnology.

[59]  P. Wang,et al.  Enhancing GDP-fucose production in recombinant Escherichia coli by metabolic pathway engineering. , 2015, Enzyme and microbial technology.

[60]  J. Pronk,et al.  Pyruvate decarboxylase: An indispensable enzyme for growth of Saccharomyces cerevisiae on glucose , 1996, Yeast.

[61]  Ryosuke Nakamura,et al.  Engineering expression of the heavy metal transporter MerC in Saccharomyces cerevisiae for increased cadmium accumulation , 2010, Applied Microbiology and Biotechnology.